MedElevator Войти в исследования
← Поиск публикаций

DOI 10.20452/pamw.16959

Медицинская библиотека · Polish archives of internal medicine · 2025

Changes in lipoprotein(a) concentrations in patients with acute coronary syndrome.

Bos Saskia, Hellemons Merel, Dave Kavita, Engel Maarten F M, Holm Are, Morlacchi Letizia, Müller Veronika, Pavanello Stefano, Picard Clément, Rossi Veronica, Saez-Gimenez Berta, Gottlieb Jens, Vos Robin

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

INTRODUCTION

Recently, interest has been growing in lipoprotein(a) (Lp[a]) as an independent risk factor for cardiovascular diseases. European Society of Cardiology recommends a single measurement of Lp(a) concentration as a guide to determine cardiovascular risk group and appropriate treatment. Although initially assumed to be genetically determined, a growing number of reports indicate that Lp(a) concentration may change over time.

OBJECTIVES

The aim of the study was to compare changes in the concentration of Lp(a) in patients with acute coronary syndrome (ACS) at the moment of ACS and 3 months later.

PATIENTS AND

METHODS

Forty patients with ACS were enrolled and divided into ST‑segment elevation myocardial infarction (STEMI) and non‑STEMI (NSTEMI) + unstable angina (UA) groups. The levels of lipids, C‑reactive protein, high‑sensitivity troponin T, N-terminal pro-B-type natriuretic peptide, and Lp(a) were determined using routine laboratory methods, with interleukin‑33 levels measured using an enzyme‑linked immunosorbent assay.

RESULTS

Among all ACS patients, 9 (22.5%) had elevated Lp(a) levels (>75 nmol/l). This proportion was higher in the STEMI (n = 8; 35%) than NSTEMI+UA (n = 2; 13%) patients. All patients with ACS showed significantly higher serum Lp(a) levels 3 months after ACS. The Lp(a) level at the moment of ACS and 3 months later differed markedly in the STEMI patients (P = 0.03), all patients with ACS (P = 0.003), and NSTEMI+UA individuals (P = 0.003).

CONCLUSION

Measuring Lp(a) level during ACS may be insufficient for accurate diagnosis and effective treatment, as its concentration increases 3 months post‑ACS. Therefore, ACS may be regarded as another nongenetic factor influencing Lp(a) concentration.

Для цитирования: Bos Saskia, Hellemons Merel, Dave Kavita, Engel Maarten F M, Holm Are, Morlacchi Letizia, Müller Veronika, Pavanello Stefano, Picard Clément, Rossi Veronica, Saez-Gimenez Berta, Gottlieb Jens, Vos Robin. Changes in lipoprotein(a) concentrations in patients with acute coronary syndrome.. Polish archives of internal medicine. 2025. DOI: 10.20452/pamw.16959.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.